Anti-neoplastic Therapy Market is expected to be valued at USD 134 Billion in 2022, Increase in the R&D activities for the Eradicating Cancer

According to Precision Business Insights (PBI), the latest report, the market value of the anti-neoplastic therapy market is expected to be valued at USD 134 billion in 2022, which is expected to grow at a CAGR of 7.8% from 2022-2028. The primary factors that drive the market are the increasing demand for personalized medicines, the growing prevalence of cancer, an increase in research and development activities in biotechnology and pharmaceutical companies along with technological progression in anti-neoplastic therapy.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/anti-neoplastic-therapy-market/

Chemotherapeutic Implant to Dominate the Anti-Neoplastic Therapy Market:
Based on product type, the chemotherapeutic agent holds the highest market share. The major factor for the rise of this segment is that the drugs are easily available. It is expected that the number of cancer patients can increase in manifolds in the upcoming years. Apart from this, effective treatment of chemotherapeutics and the ability of this technique to stop the spreading of cancerous cells far away from the initial tumor cell can drive market growth further. Technologically advanced products and government initiatives to promote awareness about chemotherapeutics can also boost market growth.

Asia Pacific Anti-Neoplastic Therapy Market:
Asia Pacific region is expected to grow significantly in the global anti-neoplastic therapy market over the forecast period. The Asia Pacific region is expanding as a result of an increase in research and development activities in academic institutes and laboratories, increasing cancer cases, and awareness among the people for personalized medications. North America leads the global market due to entrenched research infrastructure, increasing funding from public and private sectors, and rising collaborations among global key players have contributed to increasing the sales of anti-neoplastic therapy in this region. Apart from this, the major factor that drives the market in this region is the high prevalence of chronic diseases such as cancer. According to NIH, 1,806,509 people were diagnosed with cancer in the United States and 606,520 cases of death were reported.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global lateral flow assay further reveals that the key players are implementing strategies such as the extension of product collection through research and development activities, product launches, acquisitions, mergers, and strategic alliances to improve their market position and strengthen the market revenue share. In March 2021, ImmunityBio, Inc. merged with NantKwest to form immunotherapy and late-stage cell therapy firm that focuses on infectious diseases and oncology. In November 2021, extensive research was done by Rosewell Park Comprehensive, a cancer clinic in New York, that demonstrated that there is a strong relation between stress and cancer.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=58805

The anti-neoplastic therapy market is segmented based on, agent type, product type, cancer type, end users, and region.
Based on the agent type, the market is segmented into the following:
• Alkylating and Alkylating-Like Agents
• Antimetabolites
• Antitumor Antibiotics
• Plant Alkaloids
• Hormonal Agents
• Miscellaneous Agents

Based on the product type, the market is segmented into the following:
• Chemotherapeutic Agents
• Immunotherapeutic Agents
• Personalized Medicine

Based on the cancer type, the market is segmented into the following:
• Bladder Cancer
• Prostate Cancer
• Blood Cancer
• Melanoma
• Breast Cancer
• Throat Cancer
• Kidney Cancer
• Uterine Cancer
• Lungs Cancer
• Others

Based on the end users, the market is segmented into the following:
• Hospitals
• Clinics
• Research Institutes
• Cancer Rehabilitation Centers
• Others

Based on the region, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=58805

Key players' profiles in the anti-neoplastic therapy market report are AbbVie Inc., Pfizer Inc., Boehringer Ingelheim, Bayer AG, Eli Lilly and Company, Amgen Inc., Johnson and Johnson, Merck and Co., Teva Pharmaceutical Industries Ltd, and AstraZeneca Inc.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.